Leukocyte telomere length is inversely correlated with plasma Von Willebrand factor

Thrombosis Research

Volumn 125, Issue 6, 2010, Pages

  Hjelmborg, Jacob v B ^a   Nzietchueng, Rosine ^b,c   Kimura, Masayuki ^d   Gardner, Jeffrey P ^d   Bladbjerg, Else M ^a   Christensen, Kaare ^a   Aviv, Abraham ^d   Benetos, Athanase ^b,c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c INSERM   (France)

^d University of Medicine and Dentistry of New Jersey Medical School   (United States)

Author keywords

Atherosclerosis; Hypertension; Telomere; Von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHROMOSOME SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LEUKOCYTE; LEUKOCYTE METABOLISM; LEUKOCYTE STRUCTURE; MAJOR CLINICAL STUDY; MALE; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; SEX DIFFERENCE; TELOMERE; AGE; BLOOD CLOTTING; COHORT ANALYSIS; CYTOLOGY; INFORMATION PROCESSING; MIDDLE AGED; REGRESSION ANALYSIS; ULTRASTRUCTURE; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; COHORT STUDIES; DATA COLLECTION; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEX FACTORS; TELOMERE; VON WILLEBRAND FACTOR;

EID: 77952546453     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.03.006     Document Type: Article

References (38)

1. Benetos A., Gardner J.P., Zureik M., Labat C., Xiaobin L., Adamopoulos C., et al. Short telomeres are associated with increased carotid artery atherosclerosis in hypertensive subjects. Hypertension 43 (2004) 182-185
2. O'Donnell C.J., Demissie S., Kimura M., Levy D., Gardner J.P., White C., et al. Leukocyte telomere length and carotid artery intimal medial thickness: The Framingham Heart Study. Arterioscler Thromb Vasc Biol 28 (2008) 1165-1171
3. Samani N.J., and van der Harst P. Biological ageing and cardiovascular disease. Heart 94 (2008) 537-539
4. Aviv A. Telomeres and somatic fitness. Gerontol A Biol Sci Med Sci 61 (2006) 871-873
5. Gutierrez J., Ballinger S.W., Darley-Usmar V.M., and Landar A. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res 99 (2006) 924-932
6. Ross R. Atherosclerosis{box drawings light horizontal} an inflammatory disease. N Engl J Med 340 (1999) 115-126
7. Vischer U.M. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 4 (2006) 1186-1193
8. Kearney-Schwartz A., Rossignol P., Bracard S., Felblinger J., Fay R., Boivin J.M., et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 40 (2009) 1229-1236
9. Bathum L., Petersen H.C., Rosholm J.U., Hyltoft Petersen P., Vaupel J., and Christensen K. Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clin Chem 47 (2001) 81-87
10. Benetos A., Okuda K., Lajemi M., Kimura M., Thomas F., Skurnick J., et al. Telomere length as indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 37 part 2 (2001) 381-385
11. Fitzpatrick A.L., Kronmal R.A., Gardner J.P., et al. Leukocyte Telomere Length and Cardiovascular Disease in the Cardiovascular Health Study. Am J Epidem 165 (2007) 14-21
12. Gardner J.P., Li S., Srinivasan S.R., Chen W., Kimura M., Lu X., et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation 11 (2005) 2171-2177
13. Aviv A., Valdes A., Gardner J.P., Swaminathan R., Kimura M., and Spector T.D. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J Clin Endocrinal Metab 91 (2006) 635-640
14. Adaikalakoteswari A., Balasubramanyam M., Ravikumar R., Deepa R., and Mohan V. Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy. Atherosclerosis 195 (2007) 83-89
15. Valdes A., Andrew T., Gardner J.P., Kimura M., Oelsner E., Cherkas L.F., et al. Obesity, cigarette smoking, and telomere length in women. Lancet 366 (2005) 662-664
16. Vasan R.S., Demissie S., Kimura M., Cupples L.A., Rifai N., White C., et al. Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study. Circulation 117 (2008) 1138-1144
17. Hunt S.C., Chen W., Gardner J.P., Kimura M., Srinivasan S.R., Eckfeldt J.H., et al. Leukocyte telomeres are longer in African Americans than in whites: the National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study. Aging Cell 7 (2008) 451-458
18. Jeanclos E., Schork N.J., Kyvik K.O., Kimura M., Skurnick J.H., and Aviv A. Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension 36 (2000) 195-200
19. Yang Z., Huang X., Jiang H., Zhang Y., Liu H., Qin C., et al. Short telomeres and prognosis of hypertension in a Chinese population. Hypertension 53 (2009) 639-645
20. Bekaert S., De Meyer T., Reitzschel E.R., De Buyzere M.L., De Bacquer D., Langlois M., et al. Telomere length and cardiovascular risk factors in middle-aged population free of overt cardiovascular disease. Aging Cell 6 (2007) 639-647
21. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 101 (2004) 17312-17315
22. Cherkas L.F., Aviv A., Valdes A.M., Hunkin J.L., Gardner J.P., Surdulescu G.L., et al. The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell 5 (2006) 361-365
23. Blann A.D. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost 95 (2006) 49-55
24. Mertens I., Van der Planken M., Corthouts B., and Van Gaal L.F. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?. Metabolism 55 (2006) 650-655
25. Meigs J.B., O'donnell C.J., Tofler G.H., Benjamin E.J., Fox C.S., Lipinska I., et al. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 55 (2006) 530-537
26. Gómez-Ambrosi J., Salvador J., Silva C., Pastor C., Rotellar F., Gil M.J., et al. Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin. Thromb Haemost 95 (2006) 991-996
27. Blann A.D., Bushell D., Davies A., Faragher E.B., Miller J.P., and McCollum C.N. von Willebrand factor, the endothelium and obesity. Int J Obes Relat Metab Disord 17 (1993) 723-725
28. Varughese G.I., Patel J.V., Tomson J., and Lip G.Y. Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation. Heart 93 (2007) 495-499
29. Arikan E., and Sen S. Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors. Clin Appl Thromb Hemost 11 (2005) 147-159
30. Felmeden D.C., Spencer C.G., Chung N.A., Belgore F.M., Blann A.D., Beevers D.G., et al. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]). Am J Cardiol 92 (2003) 400-405
31. Lippi G., Franchini M., Targher G., Poli G., and Guidi G.C. The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement. Clin Chim Acta 381 (2007) 167-170
32. With Notø A.T., Bøgeberg Mathiesen E., Amiral J., Vissac A.M., and Hansen J.B. Endothelial dysfunction and systemic inflammation in persons with echolucent carotid plaques. Thromb Haemost 96 (2006) 53-59
33. Ramsay S., Lowe G.D., Whincup P.H., Rumley A., Morris R.W., and Wannamethee S.G. Relationships of inflammatory and haemostatic markers with social class: results from a population-based study of older men. Atherosclerosis 197 (2008) 654-661
34. Sidorov I., Kimura M., Yashin A., and Aviv A. Leukocyte Telomere Dynamics and Human Hematopoietic Stem Cell Kinetics during Somatic Growth. Exp Hematol 37 (2009) 514-524
35. Weber C., Zernecke A., and Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 8 (2008) 802-815
36. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann NY Acad Sci 908 (2000) 99-110
37. Hall D.B., Holmlin R.E., and Barton J.K. Oxidative DNA damage through long-range electron transfer. Nature 382 (1996) 731-735
38. Yoshimoto M., and Yoder M.C. Developmental biology: Birth of the blood cell. Nature 457 (2009) 801-803